SEC Form 4Coverage since May 27, 2026
$CORT insider trading
Over the last 12 months, Corcept Therapeutics insiders reported no purchases and 19 sales totaling $38.4M across SEC Form 4 filings. 84% of the activity was filed under pre-arranged 10b5-1 trading plans.
- Bought · 12m
- — 0 events
- Sold · 12m
- $38.4M 19 events
- Events · 12m
- 19 Form 4 filings, grouped
- Insiders · 12m
- 7 distinct reporters
- 10b5-1 share
- 84% pre-arranged plans
Side
Price · $CORT · 12Mvia TradingView
Top insiders · 12m
Maduck SeanSee Remarks6× · $11.2M
Mokari AtabakChief Financial Officer4× · $18.7M
Guyer WilliamChief Development Officer3× · $3.7M
Lyon Joseph DouglasSee Remarks2× · $501K
WILSON JAMES N—2× · $1.7M
All insider trades
19 events
| Date | Insider | Type | Shares | Avg price | Value | Δ stake | Marks |
|---|---|---|---|---|---|---|---|
| Aug 4, 2026 | Guyer WilliamChief Development Officer · O | ▼ Sale | 3,700 | $113.12 | $419K | -48.1% | plan |
| Aug 3, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 20,305 | $114.7 | $2.3M | -67.5% | plan |
| Aug 3, 2026 | Lyon Joseph DouglasSee Remarks · O | ▼ Sale | 1,540 | $114.16 | $176K | -21.9% | — |
| Jul 30, 2026 | Mokari AtabakChief Financial Officer · O | ▼ Sale | 80,000 | $114.71 | $9.2M | -83.2% | plan · 13 tranches |
| Jul 15, 2026 | WILSON JAMES ND | ▼ Sale | 10,000 | $88.3 | $883K | -0.9% | plan · 4 tranches · indirect |
| Jul 15, 2026 | Mokari AtabakChief Financial Officer · O | ▼ Sale | 40,000 | $87.71 | $3.5M | -71.3% | plan · 4 tranches |
| Jul 7, 2026 | Guyer WilliamChief Development Officer · O | ▼ Sale | 20,000 | $93.13 | $1.9M | -83.4% | plan · 2 tranches |
| Jul 1, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 25,000 | $88.35 | $2.2M | -71.9% | plan · 3 tranches |
| Jun 17, 2026 | MAHONEY DAVID LD | ▼ Sale | 20,000 | $84.53 | $1.7M | -43.3% | indirect |
| Jun 16, 2026 | WILSON JAMES ND | ▼ Sale | 10,000 | $83.2 | $832K | -0.9% | plan · 2 tranches · indirect |
| Jun 15, 2026 | Mokari AtabakChief Financial Officer · O | ▼ Sale | 40,000 | $81.15 | $3.2M | -71.3% | plan · 4 tranches |
| Jun 2, 2026 | Guyer WilliamChief Development Officer · O | ▼ Sale | 20,000 | $70.6 | $1.4M | -83.4% | plan |
| Jun 1, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 3,931 | $70.75 | $278K | -30.5% | plan |
| Jun 1, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 21,069 | $70.11 | $1.5M | -62% | plan |
| Jun 1, 2026 | Mokari AtabakChief Financial Officer · O | ▼ Sale | 40,000 | $70 | $2.8M | -72.4% | plan |
| Jun 1, 2026 | BELANOFF JOSEPH KChief Executive Officer · O·D | ▼ Sale | 12,837 | $69.74 | $895K | -0.5% | plan · indirect |
| May 27, 2026 | Lyon Joseph DouglasSee Remarks · O | ▼ Sale | 5,000 | $65 | $325K | -44.5% | — |
| May 27, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 20,425 | $66.16 | $1.4M | -69.5% | plan |
| May 27, 2026 | Maduck SeanSee Remarks · O | ▼ Sale | 54,575 | $65.37 | $3.6M | -65% | plan |
About Form 4
Corporate insiders — officers, directors and 10%+ owners — must report their trades to the SEC on Form 4 within two business days. We group each filing's transactions into one economic event (a laddered 10b5-1 sale is one event, not 25 rows), flag pre-arranged plans and late filings, and link every event to its AI-scored article in the $CORT feed.